Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.9033
-0.0758 (-7.74%)
Apr 23, 2026, 4:00 PM EDT - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $25.27 million as of April 23, 2026. Its market cap has decreased by -52.88% in one year.
Market Cap
25.27M
Enterprise Value
-45.32K
1-Year Change
-52.88%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $25.27M, a decrease of -79.41%. That is a compound annual growth rate of -22.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 27.41M | -46.47% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 32.03M |
| CEL-SCI | 31.89M |
| Lantern Pharma | 30.94M |
| IGC Pharma | 30.57M |
| Longeveron | 30.45M |
| Tvardi Therapeutics | 30.21M |
| Kyntra Bio | 29.70M |
| Apollomics | 29.05M |